Financial Incentives for Smoking Treatment II

NAEnrolling by invitationINTERVENTIONAL
Enrollment

1,058

Participants

Timeline

Start Date

January 6, 2020

Primary Completion Date

December 31, 2024

Study Completion Date

June 30, 2025

Conditions
Smoking CessationTobacco Use Cessation
Interventions
BEHAVIORAL

Smoking cessation counseling (Quitline)

Quitline offers community-based counseling session with a cessation counselor.

BEHAVIORAL

Smoking cessation pharmacotherapy (e.g, nicotine replacement therapy)

Participants will be encouraged to speak to their doctors about using highly effective pharmacotherapies for smoking cessation.

BEHAVIORAL

Financial incentives for smoking cessation

Participants will receive financial incentives for bioconfirmed smoking cessation.

BEHAVIORAL

Financial incentives for use of evidence-based smoking cessation therapies

Participants will receive financial incentives for the use of evidence-based smoking cessation therapies including Quitline counseling, community-based smoking cessation programs and pharmacotherapies

Trial Locations (2)

10016

NYU Langone Health, New York

90095

David Geffen School of Medicine, Los Angeles

All Listed Sponsors
collaborator

NYU Langone Health

OTHER

collaborator

Olive View-UCLA Education & Research Institute

OTHER

lead

University of California, Los Angeles

OTHER